MKI67 and breast cancer: In patients with Tε2 breast cancer who are potential candidates for cyclin inhibitors and have cN0 with a higher ratio of tumor dimension to Ki67 proliferation index, intraoperative evaluation of SNLB can be conducted in order to avoid secondary surgery and reduce the time between surgery and the beginning of adjuvant treatment.